Detailed price information for Taysha Gene Therapies Inc (TSHA-Q) from The Globe and Mail including charting and trades.

Open Text's consensus analyst price target has inched higher this week, rising from $39.39 to $40.45. This modest revision reflects heightened optimism among analysts, driven largely by the company’s ...

MP Materials shares surged on Wednesday after the company announced a joint venture with Saudi Arabia’s Ma’aden to build a ...

MP Materials shares are rising Wednesday after the company announced a partnership with the U.S. Department of War and Saudi ...

Paintmakers AkzoNobel and Axalta Coating Systems said they reached an agreement for an all-stock merger that is set to create a global paint giant with a combined market value of some $17 billion, ...

The embedded finance market in the UAE offers opportunities across multiple sectors driven by bank API modernization, fintech ...

The Ontario Securities Commission (OSC) has published an update to the dashboard of exempt market data on capital raising activity by Canadian corporate (non-investment fund) issuers in Ontario's ...

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's ...

Producers of metals and other raw materials fell amid a shifting outlook for interest rates. The SPDR Select Sector Materials exchange-traded fund, which had been among the market leaders earlier in ...

Saputo Inc. (TSX: SAP) (Saputo or the Company), announced today that it has received approval from the Toronto Stock Exchange (TSX) to renew ...

CEO Capone announced, "we are reducing our revenue guidance from $21.5 million to $18.5 million," citing decreased BARDA ...

The company also shared full-year 2026 preliminary expectations for 19% to 21% revenue growth and $615 million to $645 million in Adjusted EBITDA, representing growth of 16% to 22% year-over-year.